TY - JOUR AU - F Angrilli, AU - E Pennese, AU - A Di Marzio, AU - E Liberatore, AU - R Di Lorenzo, AU - G Fioritoni, PY - 2002/11/01 Y2 - 2024/03/29 TI - A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma JF - Haematologica JA - haematol VL - 87 IS - 11 SE - Letters to the Editor DO - 10.3324/%x UR - https://haematologica.org/article/view/2559 SP - 1227-1229 AB - We treated 30 consecutive untreated patients aged > 70 years with advanced aggressive non-Hodgkin's lymphoma with 6 courses of cyclophosphamide, mitoxantrone, etoposide, bleomycin, vinblastine and dexamethasone (D-VICEMB). The global response was 93%. The 6-year overall survival and progression-free survival were 50%, and disease-free survival was 63%. ER -